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Recent studies have shown that histone proteins can act as antimicrobial peptides in host defense against
extracellular bacteria, fungi, and Leishmania promastigotes. In this study, we used human recombinant histone
proteins to further study their leishmaniacidal effects and the underlying mechanisms. We found that the
histones H2A and H2B (but not H10) could directly and efficiently kill promastigotes of Leishmania amazonen-
sis, L. major, L. braziliensis, and L. mexicana in a treatment dose-dependent manner. Scanning electron
microscopy revealed surface disruption of histone-treated promastigotes. More importantly, the preexposure
of promastigotes to histone proteins markedly decreased the infectivity of promastigotes to murine macro-
phages (Ms) in vitro. However, axenic and lesion-derived amastigotes of L. amazonensis and L. mexicana were
relatively resistant to histone treatment, which correlated with the low levels of intracellular H2A in treated
amastigotes. To understand the mechanisms underlying these differential responses, we investigated the role
of promastigote surface molecules in histone-mediated killing. Compared with the corresponding controls,
transgenic L. amazonensis promastigotes expressing lower levels of surface gp63 proteins were more
susceptible to histone H2A, while L. major and L. mexicana promastigotes with targeted deletion of the
lipophosphoglycan 2 (lpg2) gene (but not the lpg1 gene) were more resistant to histone H2A. We discuss
the influence of promastigote major surface molecules in the leishmaniacidal effect of histone proteins.
This study provides new information on host innate immunity to different developmental stages of
Leishmania parasites.
Leishmaniasis is a sand fly-transmitted tropical disease that
threatens 350 million people in the world. It is estimated that
12 million people are infected, and the mortality rate is ap-
proximately 60,000 per year (33). Based on clinical symptoms,
the disease can be classified as visceral, cutaneous, and/or
mucocutaneous leishmaniasis. Visceral leishmaniasis is mainly
caused by Leishmania donovani and L. infantum, while the
cutaneous and mucosal leishmaniasis forms are caused by sev-
eral Leishmania species, including L. major in Old World
countries and L. amazonensis and L. braziliensis in New World
countries (11, 23). Leishmania parasites are present as extra-
cellular promastigotes in the gut of sand flies and enter into
mammals when flies take blood meals. Promastigotes can in-
fect different cell types, including neutrophils, monocytes, mac-
rophages (Ms), and dendritic cells. At the initial infection
stage, some promastigotes are killed by the host’s innate de-
fense mechanisms, such as complement, while others success-
fully establish infection in target cells and transform into amas-
tigotes, which replicate within the phagolysosomes of the cell.
The number of leishmaniasis cases has been increasing re-
cently, presumably due to the lack of adequate methods for
vector control and efficient vaccines and the increased resis-
tance to antileishmanial drugs (7). In addition, the number of
patients with coinfection of Leishmania and HIV is increasing
in subtropical and tropical regions (30). Therefore, there is a
great need for the development of new strategies to control
leishmaniasis and to better understand the host responses to
different species and stages of Leishmania.
Leishmania’s virulence and its initial infection in mammalian
hosts are closely linked to promastigote surface molecules, one
of which is lipophosphoglycan (LPG), a glycophosphatidyl-
inositol (GPI)-anchored glycolipid expressed mostly on the
surface of promastigotes but not on amastigotes. LPG is im-
portant for promastigotes to interact with the sand fly midgut
and to establish infection in mammals (46, 49). Another im-
portant molecule involved in promastigote uptake by host Ms
and which protects promastigotes from phagolysosome degra-
dation is gp63, a zinc protease expressed mainly on the surface
of promastigotes (45). However, variations in LPG and gp63
do exist among different Leishmania species and contribute to
the diverse outcome of host-parasite interactions (34).
Recently, Peters et al. have elegantly described the early
events of infection triggered by the sand fly-transmitted L.
major, confirming that neutrophils were the most abundant
cells that migrated into the wound sites (38). Within the site of
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infection initiated by microbes, neutrophils are known to
phagocytize the microbes and kill them by different mecha-
nisms (8, 32), thereby contributing to pathogen clearance in
the extracellular space (1). In the case of Leishmania infection,
neutrophils appear to play complex and paradoxical roles: their
detrimental roles are evidenced by findings that neutrophils
promote promastigote infection via spreading parasites into
Ms (1), whereas reports of their protective roles stem from
observations that depletion of neutrophils results in increased
parasite burdens after infection with L. major or L. donovani in
susceptible mice (6, 26). More recently, it was shown that
neutrophils can secrete an extracellular fibril network called a
neutrophil extracellular trap (NET), which can kill extracellu-
lar bacteria, fungi, and L. amazonensis promastigotes (3, 12,
52). This NET-related parasite killing is partially attributed to
the histone proteins because of the reduced promastigote kill-
ing following blockage with an anti-histone H2A antibody and
the enhanced promastigote killing following treatment with
histone H2A purified from calf thymus (12). Histones are
traditionally known as major components of the nucleo-
some, playing an important role in gene transcription in eu-
karyotic cells. They are classified as core histones (H2A, H2B,
H3, and H4) and linker histones (H1 and H5) and share similar
structural features and localization; however, their molecular
masses vary from 14 kDa (H2A and H2B) to 21 kDa (H1) (20).
Some histone proteins have also been shown to serve as anti-
microbial proteins to certain bacteria and fungi (19); however,
it remains unclear whether histone proteins have general or
selective effects on different Leishmania species and develop-
mental stages; if so, the mechanism(s) underlying these effects
should be examined.
In this study, we used recombinant human histone H2A and
H2B to examine their effects on parasite growth in vitro and on
parasite infectivity to Ms. We found that human histone H2A
and H2B (but not H10) efficiently and directly killed several
species of Leishmania promastigotes and that histone-treated
promastigotes had markedly decreased parasite infectivity to
murine Ms. However, L. amazonensis and L. mexicana amas-
tigotes, the disease-forming stage of the parasite, were highly
resistant to histone treatment. The mechanisms underlying
these differential responses to histone proteins were examined
by using promastigotes with altered expression levels for gp63
and LPG. Our findings open a new area of investigation and
provide insight into differential responses of Leishmania and
developmental stages to host innate responses.
MATERIALS AND METHODS
Mice. Female BALB/c mice (Harlan Sprague-Dawley, Indianapolis, IN) were
used in the study. Mice were maintained under specific-pathogen-free conditions
and used at 6 to 8 weeks of age. All of the protocols were approved by the
Animal Care and Use Committee of the University of Texas Medical Branch
(Galveston, TX).
Parasite species and cultivation. The infectivity of L. amazonensis (RAT/BA/
74/LV78), L. braziliensis (MHOM/BR/79/LTB111), and L. major (MRHO/SU/
59/P/LV39) was maintained by regular passage through BALB/c mice. Promas-
tigotes were cultured at 23°C in Schneider’s Drosophila medium (Invitrogen,
Grand Island, NY), pH 7.0, supplemented with 20% fetal bovine serum (FBS;
HyClone, Logan, UT), 2 mM L-glutamine, and 50 g/ml gentamicin. L. mexicana
promastigotes, which were originally isolated from a patient (53), were cul-
tured at 26°C in M199 medium. Unless specified, the stationary-stage pro-
mastigotes were used in all of the experiments. In some cases, metacyclic
promastigotes were purified and used. Axenic amastigotes of L. amazonensis
and L. mexicana were cultured at 33°C in complete Grace’s insect cell culture
medium (Invitrogen, Grand Island, NY), supplemented with 20% FBS,
pH 5.2.
Wild-type (WT) L. major LV39 clone 5 (Rho/SU/59/P) and the homozygous
gene-targeted deletion and add-back promastigotes (lpg1, lpg1/LPG1, lpg2,
and lpg2/LPG2) generated from the parental Lv39c5 clone (48, 50) were
grown in M199 medium (Invitrogen) with 10% FBS, 40 mM HEPES, 0.1 mM
adenine, 1 g/ml biotin, 5 g/ml hemin, 2 g/ml biopterin, and 100 U/ml peni-
cillin-streptomycin at 26°C. For the lpg1 mutants, the culture medium contained
15 g/ml hygromycin B (Cellgro, Herndon, VA) and 10 g/ml puromycin (In-
vivogen, San Diego, CA). For lpg1/LPG1 parasites, the culture medium
contained 15 g/ml hygromycin B, 10 g/ml puromycin, and 50 g/ml Geneticin
(G418; Mediatech, Inc., Manassas, VA). For lpg2 mutants, the culture medium
contained 15 g/ml hygromycin B. For lpg2/LPG2 parasites, the culture
medium contained hygromycin B and G418 (both at 15 g/ml). The expression
levels of LPG in these parasites were confirmed via Western blotting assays (data
not shown). The lpg2 L. mexicana parasites were similarly cultured.
L. amazonensis (MPRO/BR/72/M1845, LV78) promastigotes were transfected
with the P6.5 vector alone (control) or with the gp63 gene either in the correct
(P6.5/1.9, sense mutant) or in the reverse (P6.5/1.9R, antisense mutant) orien-
tation (5). Transfected promastigotes were cultured in Schneider’s Drosophila
medium, pH 7.0, supplemented with 20% FBS, 2 mM L-glutamine, and 50 g/ml
gentamicin, and under the selective pressure of tunicamycin (10 g/ml; Sigma),
the gp63 levels were upregulated in P6.5/1.9 parasites but downregulated in
P6.5/1.9R parasites (data not shown).
Parasite proliferation after histone treatment. Recombinant human histone
H2A (GenBank accession number AY131974), H2B (GenBank accession num-
ber AY131979), and H10 (GenBank accession number X03473) were purchased
from New England BioLabs (Ipswich, MA). Bulk, stationary-phase promastig-
otes of L. amazonensis (2.5  106 in 50 l of sterile PBS) were treated with
histone H2A or H2B (20 to 100 g/ml) for 3, 30, 60, and 90 min. Complete
Schneider’s medium was added to stop the reaction. Parasite survival was esti-
mated by cultivation of parasites in 96-well plates in the complete medium at
23°C. After 24 h of incubation, [3H]thymidine (GE Healthcare, United King-
dom) was added for an additional 18 h of incubation. Thymidine incorporation
was measured by a TopCount NXT microplate scintillation and luminescence
counter (Packard Bioscience Company, Shelton, CT).
Direct killing of parasites. Parasites (2.5 106 in 50 l PBS) were treated with
histone H2A or H2B (20, 100, and 200 g/ml) for 30 min at 23°C (for promas-
tigotes) or at 33°C (for amastigotes). A Live/Dead viability/cytotoxicity kit (In-
vitrogen, Eugene, OR) was used to measure the percentages of live versus dead
parasites by staining with 10 M calcein AM and 5 M ethidium homodimer-1
(EthD-1). Stained parasites were either directly counted under an Olympus
fluorescence microscope (Leeds Instruments, United Kingdom) equipped with
filters for fluorescein isothiocyanate (FITC) (live parasites) or Texas Red (dead
parasites) or subjected to analysis by using a C6 flow cytometer (Accuri Cytom-
eters, Inc., Ann Arbor, MI). The flow cytometric data were analyzed with CFlow
software (Accuri Cytometers, Inc.). The heat-inactivated parasites (56°C for 30
min) were all stained red, validating the accurate detection of death parasites
using this assay.
M cultivation and infection. Bone marrow-derived macrophages (BM-Ms)
were generated by the methods in our previous report (40). Briefly, marrow cells
(2 105/ml) were cultured in Iscove’s modified Dulbecco’s medium (Invitrogen)
supplemented with 10% FBS, 1 mM sodium pyruvate, 50 M 2-mercaptoetha-
nol, 50 g/ml gentamicin, 100 U/ml penicillin, and 20 ng/ml recombinant murine
macrophage colony-stimulating factor (M-CSF) (PeproTech, Rocky Hill, NJ) for
10 days. BM-Ms were washed twice and cultured on 24-well tissue culture
plates (4  105 cells/well). Promastigotes, axenic amastigotes, and lesion-derived
amastigotes were treated with different concentrations (20 to 100 g/ml) of
histone H2A or H2B for 30 min. Cells were infected with promastigotes or axenic
amastigotes at 5:1 parasite/cell ratios and with lesion-derived amastigotes at 1:2
parasite/cell ratios. Infected Ms were incubated at 33°C for 72 h and washed. To
quantify intercellular parasites, infected Ms were treated with 200 l 0.01%
SDS for 10 to 15 min at 37°C, and then 800 l culture medium was added to stop
cell lysis. The number of amastigotes per well was determined with a hemocy-
tometer.
To quantify parasite loads, we also extracted genomic DNA from Ms by using
a Qiagen minikit (Qiagen, Germantown, MD), and 50 ng of DNA was used for
real-time PCR analysis in the Molecular Genomics Core Laboratory at the
University of Texas Medical Branch (UTMB), as described in our previous
report (47). Each sample was run in duplicate, and the results were normalized
by the amount of total DNA extracted. The numbers of parasites per sample
were then calculated based on a standard curve, which was generated for each
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PCR by using a DNA mixture that contained 50 ng of uninfected M DNA and
increasing amounts of L. amazonensis amastigote DNA. In general, 1 pg of
amastigote DNA was equivalent to 12.4 parasites, while 104 pg of amastigote
DNA was equivalent to 1.2  105 parasites.
Scanning electron microscopy (SEM). Histone-treated parasites were adhered
to coverslips precoated with 0.01% poly-L-lysine (Electron Microscopy Sciences,
Hatfield, PA) via centrifugation at 2,000 rpm for 5 min. Samples were fixed at 4°C
overnight in a mixture of 2.5% formaldehyde and 0.1% glutaraldehyde in 0.05 M
cacodylate buffer (pH 7.2), containing 0.03% trinitrophenol and 0.03% CaCl2.
Samples were washed with 0.1 M cacodylate buffer, postfixed in 1% OsO4 in 0.1
M cacodylate buffer (pH 7.2), dehydrated in ethanol, and processed through
hexamethyldisilazane. After being air dried, coverslips were mounted onto the
specimen stubs and sputter coated with iridium in an Emitech K575x sputter
coater (Ashford, Kent, United Kingdom) at 20 mA for 20 s. Samples were
examined in a Hitachi S4700 field emission scanning electron microscope
(Hitachi High Technologies America, Electron Microscope Division, Pleasanton,
CA) at 2 kV and instrumental magnifications from 2,000 to 50,000.
Histone binding on parasites. Promastigotes and axenic amastigotes of L.
amazonensis were treated with the previously indicated concentrations of H2A
for 30 min. Treated parasites were washed and stained on ice with a mouse
anti-human histone H2A monoclonal antibody (MAb) (Cell Signaling, Danvers,
MA) and then with FITC-conjugated rat anti-mouse IgG1 (eBioscience, San
Diego, CA). For intracellular staining, histone-treated parasites were fixed/
permeabilized with a Cytofix/Cytoperm kit (BD Biosciences, Franklin Lakes,
NJ) prior to antibody staining. Parasites were read on a C6 flow cytometer
and analyzed with CFlow software. In each staining experiment, some sam-
ples were side-by-side evaluated for the live/dead parasites, as described
above. The unstained parasite and parasites stained with the secondary an-
tibody alone gave no or negligible levels of binding (data not shown). Similar
studies were conducted with wild-type L. major promastigotes and lpg1 and
lpg2 mutants.
Statistical analysis. Differences between two groups were determined by using
Student’s t test. A one-way analysis of variance (ANOVA) was used for multiple
group comparisons. Graphs were prepared by using GraphPad Prism 4.0 (Graph-
Pad Software, San Diego, CA). The difference between two groups was consid-
ered significant when the P value was 0.05.
RESULTS
Histone H2A and H2B can suppress Leishmania promasti-
gote proliferation. To test the effect of histone proteins on
parasites, we treated stationary-phase L. amazonensis promas-
tigotes with 20 or 100 g/ml of histone H2A or H2B for 3 to 90
FIG. 1. Suppressive effects of histone H2A and H2B on parasite
proliferation. L. amazonensis promastigotes (2.5  106 in 50 l PBS)
were treated with 20 or 100 g/ml of histone H2A (A) or H2B (B) at
23°C for indicated time periods, after which complete Schneider’s
medium was added. After 24 h of incubation, [3H]thymidine was added
for an additional 18 h of incubation. Incorporated [3H]thymidine was
measured and presented as counts per minute (cpm). Data are pooled
from two independent repeats and shown as the means the standard
errors. * (P  0.05) and ** (P  0.01) indicate statistically significant
differences between the control and treated groups. # (P  0.05) and
## (P  0.01) indicate the statistical differences between the marked
groups.
FIG. 2. Direct killing of Leishmania promastigotes, but not amas-
tigotes, by histone proteins. Promastigotes of L. amazonensis (A and
B), L. major (C), and L. braziliensis (D) were treated with 20 to 200
g/of of histone H2A, H2B, or H10 for 30 min and then stained with
calcein AM and ethidium homodimer for evaluating live (green) versus
dead (red) parasites, respectively. Shown are representative results
from three independent repeats, and data are presented as mean
survival rates (%)  standard errors. ** (P  0.01) and *** (P 
0.001) indicate statistically significant differences between the control
and treated groups. # (P  0.05), ## (P  0.01), and ### (P 
0.001) indicate the statistical differences between the marked groups.
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min and assessed the ability of surviving parasites to replicate
following addition of fresh medium. As shown in Fig. 1, a high
concentration of H2A (100 g/ml) resulted in a nearly 50%
reduction in parasite replication, as judged by [3H]thymidine
incorporation. Likewise, parasite replication of H2B-treated
promastigotes decreased by 30 to 40% compared to their con-
trols. At a low concentration (20 g/ml), H2A and H2B had no
major effects on parasite replication, except for the H2B treat-
ment for 90 min, which showed a small (27%), but significant,
reduction in parasite replication. Therefore, the suppression of
promastigote proliferation was dependent on the histone con-
centrations, but such effects appeared to be independent of
treatment time.
Histone H2A and H2B can directly kill Leishmania promas-
tigotes but not amastigotes. The reduced thymidine incorpo-
ration seen above could be due to parasite death or replication
arrest. To examine whether histones can kill promastigotes
directly, we treated promastigotes of L. amazonensis, L. bra-
ziliensis, and L. major with histones (20 to 200 g/ml), and then
used fluorescent reagents to stain live (green) versus dead
(red) parasites (Fig. 2A). It was evident that histone-treated
promastigotes had significantly lower survival rates than did
those of the untreated groups. At the concentration of 100
g/ml, for example, the survival rates of histone H2A-treated
promastigotes decreased by 40% in L. amazonensis (Fig. 2B),
49% in L. major (Fig. 2C), and 63% in L. braziliensis (Fig. 2D).
Likewise, the survival rates of histone H2B-treated promasti-
gotes decreased by 37% in L. amazonensis and by 75% in both
L. major and L. braziliensis. Compared to the other two spe-
cies, L. braziliensis promastigotes seemed more sensitive to
histone treatment, judged by the significant reduction in sur-
vival rates even at 20 g/ml of H2A or H2B (Fig. 2D). To
confirm the specific effects of H2A and H2B, we also per-
formed similar studies with histone H10, a component of chro-
FIG. 3. Analysis of the death rates of histone-treated parasites by flow cytometry. (A) Metacyclic promastigotes of L. major and L. amazonensis
were purified by using Ficoll gradient centrifugation and treated with an indicated concentration of histone H2A. Axenic amastigotes of L.
amazonensis and L. mexicana, as well as lesion-derived amastigotes of L. mexicana, were treated similarly. Parasites were stained with calcein AM
and ethidium homodimer and analyzed on a C6 flow cytometer. The numbers represent the percentages of dead (top left numbers) and live
(bottom right numbers) parasites. (B and C) Promastigotes (B) and axenic amastigotes (C) of L. amazonensis were treated with histone H2A or
H2B alone or in combination at indicated concentrations (g/ml) and analyzed as described for panel A. Shown are representative results from
two independent repeats, and data are presented as mean death rates (%)  standard errors. * (P  0.05), ** (P  0.01), and *** (P  0.001)
indicate statistically significant differences between the control and treated groups.
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matin linker proteins. In contrast to a previous report citing an
antimicrobial effect of H10 (15), we did not observe any major
changes in H10-treated L. amazonensis (Fig. 2B).
To validate and extend these findings, we purified metacyclic
promastigotes of L. amazonensis and L. major, treated them
with histone H2A, and measured parasite death rates by using
flow cytometry, a relatively sensitive method that allows accu-
rate quantification of the percentages of live versus dead par-
asites. Consistently, we detected approximately 10% and 27%
of dead metacyclic promastigotes following treatment with 20
and 100 g/ml H2A, respectively (Fig. 3A). Since Leishmania
amastigotes are the disease-forming stage of the parasite and
have a long-term interaction with the host, we examined axenic
and lesion-derived amastigotes of L. amazonensis and L. mexi-
cana. Interestingly, we consistently detected a relatively low
level of increase in the percentages of dead parasites even
when axenic amastigotes were treated with 100 g/ml of H2A,
as judged by flow cytometry (Fig. 3) and fluorescent micros-
copy (data not shown). Although lesion-derived amastigotes
reached a death rate of 6.5% following treatment with 100
g/ml of H2A (Fig. 3A), the net increase was marginal (1.5%)
compared to that of the untreated controls (4.3%). To test
whether different histone proteins have any synergic effects, we
used H2A plus H2B (each at 10 or 20 g/ml) to treat promas-
tigotes or axenic amastigotes but found no synergic effects
between H2A and H2B on promastigotes or amastigotes (Fig.
3B and C). We also tested whether low-pH conditions (pH 5)
can influence the histone killing. While the low-pH condition
by itself increased the percentages of dead promastigotes (but
not amastigotes), this low pH did not change the differential
sensitivity of these parasites to histones (data not shown).
Together, these results clearly indicate that the leishmaniacidal
effects are selective for H2A and H2B (but not H10) proteins
and are generally efficient for promastigotes. In contrast,
axenic and lesion-derived amastigotes of L. amazonensis and L.
mexicana are relatively resistant to histone treatment.
Preexposure to histone proteins markedly decreases pro-
mastigote infectivity in macrophages. Leishmania parasites
need to establish an infection and replicate within target cells
in order to trigger pathological changes. To further examine
the leishmaniacidal effects of histones, we pretreated promas-
tigotes and axenic or lesion-derived amastigotes of L. ama-
zonensis with histone proteins for 30 min and used these par-
asites to infect BM-Ms. Parasite loads were evaluated by two
different methods. First, we used 0.01% SDS to lyse Ms at
72 h of infection and counted parasite numbers per well under
a microscope. It was evident that pretreatment with 20 or 50
g/ml of H2A or H2B resulted in a significant reduction in
parasite numbers (P  0.001) (Fig. 4A). Second, we extracted
the genomic DNA from cells at 72 h of infection to examine
parasite loads by real-time PCR analysis and confirmed the
significant reduction in parasite loads when promastigotes
were pretreated with H2A or H2B (Fig. 4B). Again, we found
that histone pretreatment had no major effects on M infec-
tion by axenic or lesion-derived amastigotes (Fig. 4C), which
was consistent with our results in Fig. 3A and C. Therefore,
preexposure to histone proteins can markedly decrease the
infectivity of promastigotes, but not amastigotes, in Ms.
Morphological changes of histone-treated promastigotes.
As histone proteins can efficiently kill Leishmania promasti-
gotes, we examined the ultrastructure of histone-treated par-
asites by scanning electron microscopy (SEM) (Fig. 5A) and
measured the body length of L. amazonensis promastigotes
at 2,000 magnification. While the average length of control
parasites was 18.6 m, the average lengths of H2A- and H2B-
treated parasites were 13.5 m and 12.9 m, respectively (P 
0.001) (Fig. 5B). A close-up examination revealed that while
the control parasites displayed a smooth surface in the body
and flagellum, the surface of H2A-treated promastigotes was
uneven and disrupted (Fig. 5C). Holes of variable sizes were
observed on H2B-treated promastigotes (Fig. 5C, white ar-
rows). The similarly treated axenic amastigotes showed no
notable differences from their controls (Fig. 5D), confirming
the relative resistance of amastigotes to histone treatment (Fig.
3B and 4C).
Binding of histone proteins to Leishmania parasites. In an
attempt to examine the selective binding and localization of
histone proteins to parasites, we used anti-human histone
H2A plus FITC-conjugated secondary antibodies to stain
H2A-treated promastigotes or axenic amastigotes of L. ama-
zonensis. We consistently detected a dose-dependent increase
in the percentages of anti-H2A staining on the surface of
promastigotes (Fig. 6A) and amastigotes (Fig. 6B). When par-
FIG. 4. M infection with histone-treated L. amazonensis para-
sites. (A and B) L. amazonensis promastigotes were treated with an
indicated concentration of H2A or H2B for 30 min and used to infect
Ms (at a 5:1 parasite-to-cell ratio). The number of intracellular par-
asites was determined at 72 h by direct counting under a hemocytom-
eter (A) or via real-time PCR analysis (B). (C) Ms were infected with
histone-pretreated axenic amastigotes of L. amazonensis (at a 5:1 par-
asite-to-cell ratio) or lesion-derived amastigotes of L. mexicana (at a
1:2 parasite-to-cell ratio) for 48 h. Parasite loads were determined by
real-time PCR analysis. Shown are means standard errors. *** (P
0.001) indicates statistically significant differences between the control
groups and histone-treated groups, and NS means no significance.
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asites were treated with H2A and then permeabilized prior to
antibody staining, the percentages of internal anti-H2A stain-
ing in promastigotes were significantly higher than those in
amastigotes (comparing 2.8% with 0.8%, P  0.05). To con-
firm these observations, we calculated the ratios of internal to
surface-bound H2A. Promastigotes treated with 20 or 50 g/ml
of H2A had an average ratio of 1.3 or 4.0, respectively, whereas
amastigotes treated with 20 or 100 g/ml of H2A had an
average ratio of 0.02 or 0.4, respectively. These data imply that
the surface binding and subsequent internalization of H2A are
critical for promastigote killing.
LPG and gp63 partially contribute to the susceptibility of
promastigotes to histone proteins. The sensitivity of Leish-
mania promastigotes to histone proteins prompted us to ex-
amine the possible contribution of gp63 and LPG, the most
abundant surface molecules and important virulence factors
for promastigotes but not at all important (or in only a limited
manner) for amastigotes (28, 31). We first treated WT,
lpg1, and lpg1/LPG1 promastigotes of L. major with his-
tone H2A and analyzed the stained parasites by flow cytom-
etry. Our pooled results from several independent repeats re-
vealed no major differences among the three parasite groups
(Fig. 7A), implying a limited role for lpg1 deficiency in the
histone-mediated killing of promastigotes. To validate this ob-
servation, we incubated histone H2A (50 or 100 g/ml) with
purified L. major LPG for 30 min and then added the H2A and
LPG to WT and lpg1 parasites. In WT parasites, the mortality
rate was reduced significantly when H2A was preincubated
with 50 g/ml of LPG (P  0.001) (Fig. 7B) or 100 g/ml
LPG (P  0.05) (data not shown), leading us to postulate
that the leishmaniacidal effect of H2A was hampered by the
binding to purified LPG. However, the similar treatment had
no major effects on lpg1 parasites, implying that other pro-
mastigote surface components were involved in binding to
H2A. To examine these possibilities, we used lpg2 promas-
tigotes of L. major and L. mexicana. As shown in Fig. 7C,
histone treatment of lpg2 L. major resulted in death rates of
10%, a number about 3-fold lower than those in WT and
lpg2/LPG2 parasites (P  0.001). Likewise, the death rates
of H2A-treated L. mexicana lpg2 parasites were about 2-fold
FIG. 5. Morphological and ultrastructural changes of histone-treated parasites in scanning electron microscopy (SEM). L. amazonensis
promastigotes were treated with histone H2A or H2B (100 g/ml) for 30 min, and then samples were immediately fixed for SEM analysis.
(A) Representative SEM images for control and treated parasites. Bars, 20 m. (B) Data are shown as the average lengths of promastigotes in
the control and histone-treated groups. Shown are means  standard errors. *** (P  0.001) indicates statistically significant differences between
the control and treated groups. (C and D) L. amazonensis promastigotes (C) and axenic amastigotes (D) were left untreated or treated with histone
H2A or H2B (100 g/ml) for 30 min. Samples were fixed for SEM analysis, and images were taken at 15,000 to 20,000 magnification. Bars,
3 m (C) and 2 m (D). Arrows points to variable sizes of holes on the surface of promastigotes. F, flagellum.
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lower than those in its WT controls (P  0.05) (Fig. 7D). We
also stained L. major WT and mutant parasites with anti-
human histone H2A plus FITC-conjugated secondary antibod-
ies, as described for Fig. 6. However, we failed to obtain a
consistent trend, mostly due to the marked loss of mutant
parasites during the staining procedures (data not shown). To
investigate the involvement of gp63, we used different concen-
trations of H2A to treat L. amazonensis P6.5, P6.5/1.9R, and
P6.5/1.9 promastigotes (the latter two parasites were knock-
down or overexpression levels of gp63, respectively). At 100
g/ml of H2A, the death rates of P6.5/1.9R (gp63-knockdown)
parasites were significantly higher than those of P6.5 and P6.5/
1.9 parasites (P  0.05) (Fig. 7E). Together, these results
implied that both LPG and gp63 partially contribute to the
susceptibility of promastigotes to histone proteins.
DISCUSSION
Many components in the innate immune system can contrib-
ute to protection against invading pathogens. For example,
antimicrobial peptides (AMPs) are conserved components of
the host defense system in plants, invertebrates, and verte-
brates, and they have a wide spectrum of antimicrobial func-
tion against bacteria, fungi, viruses, and parasites (42, 43). At
least two major mechanisms are known to be responsible for
AMP-mediated pathogen killing. Some AMPs can bind to the
surface of microbes and alter their membrane permeabiliza-
tion (4), while other AMPs can directly enter the cytoplasm of
microbes, whereby killing relies on an intracellular target (35).
Several AMPs have antiprotozoan activities on promastigotes
of L. major and L. donovani (24, 25), the procyclic and blood-
stream forms of Trypanosoma brucei (13, 29), the oocysts of
Cryptosporidium parvum (10), and the intraerythrocytic form of
Plasmodium falciparum (9). However, our knowledge regard-
ing the effect of AMPs on protozoan infection is still quite
limited in comparison to that known for bacteria and fungi
(42).
In this study, we used human histone H2A and H2B to treat
Leishmania parasites. We have provided evidence that core
histone proteins H2A and H2B, but not linker histone protein
H10, can directly and efficiently kill several species of Leish-
mania promastigotes (L. amazonensis, L. major, L. braziliensis,
and L. mexicana) in a dosage-dependent and time-indepen-
dent manner. More importantly, we have shown that preexpo-
sure to relatively low concentrations of histone proteins can
greatly reduce the infectivity of promastigotes to mouse Ms.
However, histone proteins had limited effects on axenic and
lesion-derived amastigotes of L. amazonensis and L. mexicana
(Fig. 3A, 4C, and 5D). These findings indicate a general, mi-
crobicidal effect of histone proteins on Leishmania promasti-
gotes but not on amastigotes.
The differential sensitivities of promastigotes and amastigotes
to histone-mediated parasite killing, as well as the marked de-
crease in body length and the apparent damage of treated
promastigotes (Fig. 5), prompted us to examine the possible
mechanism of promastigote killing. The flow cytometric stud-
ies suggested to us that the relatively high sensitivity of pro-
mastigotes to histones is due to the efficient binding and inter-
nalization of histone proteins (Fig. 6A). Given that LPG and
gp63 are important virulence and survival factors for some
Leishmania species (48, 51) and that their expression levels are
highly regulated in parasite developmental stages (2, 39), we
then focused our investigation on LPG and gp63.
Our studies with purified LPG, gene-targeted deletion, and
transgenic parasites reveal that LPG and gp63 play complex
roles in the histones’ leishmaniacidal effects (Fig. 7) and sug-
gest a need for additional investigation in this area. First, the
enhanced susceptibility of gp63-knockdown L. amazonensis to
H2A treatment implies a potential protective role for gp63
against the action of histone proteins. Since gp63 is a major
surface zinc protease of promastigotes (27) that can inactivate
AMPs (14, 22), it will be interesting to further examine whether
our observations were due to proteolytic cleavage of histones
by surface-anchored gp63. Second, our studies with LPG-pre-
treated histone proteins implied a possible reduction in both
quantity and availability of histones for binding to parasites,
which may explain the reduced susceptibility of wild-type L.
major promastigotes to histone treatment. Third, the four main
components of Leishmania LPG may contribute to histone
FIG. 6. Surface and internal binding of histone proteins on Leishmania parasites. L. amazonensis promastigotes (A) or axenic amastigotes
(B) were treated with the indicated concentration of histone H2A for 30 min. After washing, surface-bound H2A was stained with a mouse MAb
specific to human histone H2A and then with an FITC-conjugated anti-mouse IgG1 antibody. For detecting internalized H2A, parasites were
permeabilized prior to and during antibody staining. Parasites were analyzed on a C6 flow cytometer. The numbers in the boxes indicate the
percentages of positively stained parasites, and data are presented as means (%)  standard errors. Shown are representative results from two
independent repeats.
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binding differently. Although the lpg1 mutants lack LPG (16),
they were as susceptible to H2A as were the WT promasti-
gotes, because lpg1 mutants are still capable of synthesizing
and expressing PGs attached to proteophosphoglycans (PPG)
on the surface (16). In contrast, the lpg2 mutants showed an
increased resistance to histone treatment, because these
mutants lack all PG repeats due to the deletion of the Golgi
GDP-Man transporter LPG2 but can synthesize the LPG
glycan core and protein backbone of PPG. It is reported that,
like other AMPs, some core histone proteins such as H2A can
cross lipid bilayers and mycoplasma membranes and that the
intracellular accumulation of histones is energy independent
and mediated via a nonendocytic pathway (44). At this stage,
the molecular basis underlying the translocation of histone
proteins to promastigotes remains unclear. Given marked loss
of lpg1 and lpg2 mutants in our antibody-based assay (data
not shown), we suggest that other approaches such as radio-
active-labeled H2A are needed to address this issue.
Another important finding in this study is the relatively high
resistance of axenic and lesion-derived amastigotes of L. ama-
zonensis and L. mexicana to the microbicidal effects of histone
proteins (Fig. 3 and 4), even though appreciable percentages of
amastigotes were surface positive for H2A (Fig. 6B). There are
several possible explanations for the evident surface binding,
but limited detection, of internal H2A in amastigotes. First, it
is known that amastigotes resemble the lpg1 promastigotes in
that they lack LPG1 but retain PPG (18) and that the structure
of the glycans found on amastigote PPG in L. mexicana differs
considerably from the simpler LPG-like linear PG polymers
found on promastigote PPG (17, 21). These unique structures
may allow interaction with histones but limit their transloca-
tion. Second, amastigotes reside and replicate within acidified
vacuoles and are highly enriched in proteases for the digestion
of host proteins. The possibility of degrading histone proteins,
as suggested in our studies with gp63 transfectants (Fig. 7E),
needs further investigation. Third, lesional amastigotes of L.
mexicana and amastigotes residing in phagolysosomes can se-
crete relatively large amounts of PPG, which can bind to serum
mannan-binding proteins and subsequently activate serine pro-
tease (37). Although the molecular details of surface molecules
for L. amazonensis amastigotes remain largely unclear, it will
be interesting to further examine how amastigotes protect
themselves from damage by histone proteins. Regardless of the
mechanisms, our results clearly indicate the biologically impor-
tant differences between the two parasite stages in their sen-
sitivity to histone proteins and thereby open areas for future
investigation.
Histone proteins are known to be released from activated
neutrophils during NET formation. Neutrophils are consid-
ered a major part of innate immunity and can utilize phago-
cytosis, degranulation, and NET at different time points for
host defense (36). For example, phagocytosis by neutrophils
plays a predominant role in killing freshly engulfed microbes,
while later killing is determined mostly by degranulation and/or
NET formation (36). The NET-related antimicrobial activities
can be attributed to many NET components, including his-
tones, myeloperoxidase, neutrophil elastase, bacterial perme-
ability-increasing proteins, and defensins (36). In addition,
neutrophils or purified neutrophil elastase can activate Ms to
induce a defense against L. major, a process that relies on
TLR4 expression by Ms (41). The NET-mediated killing of L.
amazonensis promastigotes is attributed to histones rather than
to DNA and elastase relayed from NETs (12). Recently, we
have found that mice deficient in the type I interferon (IFN)
receptor are less susceptible to L. amazonensis infection than
are WT mice and that enhanced neutrophil recruitment, turn-
over, and effector functions are responsible for the enhanced
resistance in the deficient mice (54). Thus, the present study
extends our understanding of histone functioning in innate
FIG. 7. Effects of LPG and gp63 on histone-mediated promastigote
killing. (A) Wild-type (WT), lpg1, and lpg1/LPG1 promastigotes
of L. major were treated with the indicated concentrations (g/ml)
of histone H2A or H2B and then stained with calcein AM and
ethidium homodimer, respectively. The stained parasites were then
analyzed on a C6 flow cytometer. (B) Histone H2A (50 g/ml) was
preincubated with purified L. major LPG (50 g/ml) for 30 min
prior to parasite treatment and death analysis. (C) WT, lpg2, and
lpg2/LPG2 promastigotes of L. major were treated with indi-
cated concentrations (g/ml) of histone H2A and analyzed for
death rates. (D) WT and lpg2 promastigotes of L. mexicana were
treated with the indicated concentrations of histone H2A and ana-
lyzed for death. (E) WT (P6.5), P6.5/1.9, and P6.5/1.9R promastigotes
of L. amazonensis were treated with the indicated concentrations of
H2A and analyzed for death. Shown are the means  the standard
errors. * (P  0.05), ** (P  0.01), and *** (P  0.001) indicate
statistically significant differences between histone-treated groups. NS
means no significance among these groups.
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immunity to Leishmania promastigotes. Additional studies are
needed to further examine the relevance of these interactions
in Leishmania infection in vivo.
In summary, our results showed that human histone proteins
are highly efficient in killing Leishmania promastigotes but not
amastigotes. The finding of the differential susceptibility of
promastigotes and amastigotes to histone proteins is interest-
ing and biologically important. This study supports the view
that histone proteins released from NETs contribute to host
immune responses to Leishmania parasites (12) and calls for
further examination of the effect of histone proteins on para-
site infection in vivo and the mechanism underlying histones’
antileishmanial function. Although our results revealed a min-
imal effect of histone proteins on Leishmania amastigotes, it
will be interesting to examine whether other NET components
can promote amastigote killing and how an amastigote-derived
factor(s) down-modulates these antileishmanial effects.
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